Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in PRQR — ProQR Therapeutics N.V.

CIK 72971 SAN FRANCISCO, CA
Back to PRQR Full portfolio

Position in PRQR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,440
+$960 QoQ
Shares Held
4,000
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 69 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRQR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. PRQR ranks #325 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in PRQR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,440 4,000
2026-03-31 $6,480 4,000
2025-12-31 $8,080 4,000
2025-09-30 $11,949 5,610
2025-06-30 $11,444 5,610
2025-03-31 $8,791 6,610
2024-12-31 $23,200 8,755
2024-09-30 $16,791 9,226
2024-06-30 $18,253 10,996
2024-03-31 $25,180 10,996
2023-12-31 $21,772 10,996
2023-09-30 $14,294 10,996
2023-06-30 $17,813 10,996
2023-03-31 $23,421 10,996
2022-12-31 $40,685 10,996
2022-09-30 $8,181 10,996
2022-06-30 $8,554 10,996
2022-03-31 $9,951 10,996
2021-12-31 $88,077 10,996
2021-09-30 $92,036 10,996
2021-06-30 $74,113 10,996
2021-03-31 $72,683 10,996
2020-12-31 $46,183 10,996
2020-09-30 $52,670 10,996
2020-06-30 $72,935 11,996
2020-03-31 $65,858 11,996